Tracking global ocean change and using nuclear energy: News from Imperial
Prestigious annual dinner celebrates the impact of philanthropy
£10 million gift to propel Imperial’s heart and lung research
CDDS researchers work across a wide range of diseases, from infection and inflammation to oncology, cardiovascular disease and neurodegeneration.
View our network of disease experts
The CDDS brings together expertise in new screening technologies, target deconvolution, ultrasensitive biomarker analysis, microfluidic devices, and more.
View technology areas
We are developing small molecule, peptide, biological and cell-based modalities across a wide range of target classes and novel modes of action.
View target classes